Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophreniaSophie Hackinger, Eleftheria Zeggini, Eirini Marouli et al.|Translational Psychiatry|2018Cited by 95
Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP studyVasiliki Mamakou, Eleftheria Zeggini, Sophie Hackinger et al.|BMC Psychiatry|2018Cited by 5